Clinical Trials

Most oncology clinical trials that stall or fail do so because they cannot enroll the right patients fast enough — not because the molecule was wrong. The bottleneck has four parts: finding the rare biomarker-positive patient, reaching patients who live where your sites are not, moving tumor tissue through a fragile testing chain, and doing all of

AI in Clinical Trials Moved From Pilot to Production — And Most Sponsors Aren’t Ready A VP of Clinical Operations spent $2.4 million on an AI platform for enrollment forecasting, site performance prediction, and protocol risk identification. The software was deployed nine months ago. Nine months later, her team still uses Excel for enrollment forecasts.

In today’s rapidly evolving life sciences landscape, building an effective regulatory strategy is no longer optional—it’s essential. For sponsors navigating complex global requirements, a well-structured regulatory approach ensures smoother approvals, minimizes delays, and strengthens overall clinical trial compliance. At eteraflex connects, we understand that success in clinical trials begins long before patient enrollment—it starts with

A Strategic Framework for Accelerating Clinical Development and Maximizing ROI Global clinical trials represent one of the largest financial investments in pharmaceutical and medical device development. Yet, despite advances in science and technology, clinical trials remain operationally inefficient. A single Phase 2 or Phase 3 trial can cost over $40,000 per day, and every day